Ibandronic Acid Activase Pharmaceuticals

Active Ingredient:: Ibandronic Acid
Origin:: EU

Ibandronic Acid Activase Pharmaceuticals (Ibandronic Acid)

Q: What is Ibandronic Acid Activase Pharmaceuticals used for?

Ibandronic Acid Activase Pharmaceuticals contains the bisphosphonate ibandronate, which is prescribed to treat osteoporosis in postmenopausal women, to prevent vertebral fractures, and to manage Paget's disease of bone by reducing excessive bone turnover.

Q: How does ibandronic acid work in the body?

Ibandronic acid binds to hydroxyapatite at active bone‑remodeling sites. When osteoclasts attach, the drug is internalised, disrupting the mevalonate pathway, leading to osteoclast apoptosis and a consequent reduction in bone resorption.

Q: What is the usual dose of ibandronic acid?

The dosing regimen for ibandronic acid is determined by the prescribing clinician based on the indication, patient characteristics, and local guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Q: Is ibandronic acid safe during pregnancy or breastfeeding?

The safety of ibandronic acid in pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit justifies the potential risk, and this decision rests with the treating physician.

Q: How do I order Ibandronic Acid Activase Pharmaceuticals from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Q: How does ibandronic acid compare with other osteoporosis treatments?

Ibandronic acid is a potent bisphosphonate taken orally, typically once monthly, offering convenient dosing compared with daily or weekly alternatives. Compared with other bisphosphonates such as alendronate, ibandronate has a similar efficacy profile but may have a different side‑effect spectrum, especially regarding gastrointestinal tolerance.

Q: What are the storage requirements for ibandronic acid tablets?

Store the tablets at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from moisture, heat, and direct sunlight to maintain stability and potency.

Q: How is ibandronic acid administered?

Ibandronic acid is taken orally as a whole tablet with a full glass of water, preferably on an empty stomach. After swallowing, the patient should remain upright for at least 30 minutes and avoid eating, drinking, or taking other medications during that period.

Q: What are the most serious risks associated with ibandronic acid?

The most serious risks include osteonecrosis of the jaw, atypical femur fractures, and severe hypersensitivity reactions such as anaphylaxis. Patients should report any persistent jaw pain, exposed bone, or unusual thigh pain to their healthcare provider promptly.

Q: Who should not use ibandronic acid?

Ibandronic acid is contraindicated in patients with severe renal impairment (eGFR <30 mL/min), known hypersensitivity to ibandronate or other bisphosphonates, and those who cannot remain upright for 30 minutes after dosing. It should also be used with caution in individuals with esophageal disorders.

Ibandronic Acid, the active ingredient in Ibandronic Acid Activase Pharmaceuticals, is a bisphosphonate presented as an oral tablet for oral use. It treats osteoporosis in postmenopausal women, helps prevent vertebral fractures, and is also indicated for Paget's disease of bone.

GNH India supplies Ibandronic Acid Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Activase Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ibandronic Acid is a bisphosphonate that acts on bone‑remodelling pathways to improve skeletal strength.

Osteoporosis in postmenopausal women: reduces bone loss and lowers the risk of vertebral and non‑vertebral fractures.
Prevention of vertebral fractures: maintains bone mineral density to help avoid new compression fractures.
Paget's disease of bone: normalises abnormal bone turnover and alleviates associated pain.

How It Works

Ibandronic Acid binds selectively to hydroxyapatite crystals at sites of active bone remodeling. When osteoclasts attach to the drug‑coated bone surface, the compound is internalized, disrupting the mevalonate pathway, inducing osteoclast apoptosis, and thereby inhibiting bone resorption.

Side Effects

Ibandronic Acid may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

Gastrointestinal discomfort: nausea, abdominal pain, or dyspepsia.
Musculoskeletal pain: transient bone, joint or muscle aches.
Headache: mild to moderate intensity.

Serious or Rare Side Effects

Osteonecrosis of the jaw: exposed bone in the oral cavity, often after dental procedures.
Atypical femur fracture: low‑energy fracture of the subtrochanteric region.
Severe hypersensitivity: rash, angioedema, or anaphylactic reaction.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and counsel on proper administration.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min).
Calcium and vitamin D status: ensure adequate supplementation to reduce hypocalcaemia risk.
Administration technique: swallow tablet with a full glass of water and remain upright for at least 30 minutes.
Concomitant gastro‑protective agents: avoid taking antacids, calcium, or multivitamins within two hours of the dose.
Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Avoid Interactions

Ibandronic Acid can interact with several medicines, altering its absorption or increasing adverse effects.

Major Interactions (Avoid)

Calcium or multivitamin supplements containing calcium within 2 hours: markedly reduces oral absorption.
Antacids containing aluminum, magnesium, or calcium: interfere with drug uptake.
Oral tetracycline antibiotics: chelation reduces bioavailability.

Moderate Interactions (Monitor Closely)

Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal irritation.
Corticosteroids: may exacerbate bone loss if used long‑term.
Warfarin: potential for altered anticoagulant effect; monitor INR.
Loop diuretics: may affect calcium balance; monitor serum electrolytes.

Frequently Asked Questions

Ibandronic Acid Activase Pharmaceuticals contains the bisphosphonate ibandronate, which is prescribed to treat osteoporosis in postmenopausal women, to prevent vertebral fractures, and to manage Paget's disease of bone by reducing excessive bone turnover.

Ibandronic acid binds to hydroxyapatite at active bone‑remodeling sites. When osteoclasts attach, the drug is internalised, disrupting the mevalonate pathway, leading to osteoclast apoptosis and a consequent reduction in bone resorption.

The dosing regimen for ibandronic acid is determined by the prescribing clinician based on the indication, patient characteristics, and local guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of ibandronic acid in pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit justifies the potential risk, and this decision rests with the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibandronic acid is a potent bisphosphonate taken orally, typically once monthly, offering convenient dosing compared with daily or weekly alternatives. Compared with other bisphosphonates such as alendronate, ibandronate has a similar efficacy profile but may have a different side‑effect spectrum, especially regarding gastrointestinal tolerance.

Store the tablets at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from moisture, heat, and direct sunlight to maintain stability and potency.

Ibandronic acid is taken orally as a whole tablet with a full glass of water, preferably on an empty stomach. After swallowing, the patient should remain upright for at least 30 minutes and avoid eating, drinking, or taking other medications during that period.

The most serious risks include osteonecrosis of the jaw, atypical femur fractures, and severe hypersensitivity reactions such as anaphylaxis. Patients should report any persistent jaw pain, exposed bone, or unusual thigh pain to their healthcare provider promptly.

Ibandronic acid is contraindicated in patients with severe renal impairment (eGFR <30 mL/min), known hypersensitivity to ibandronate or other bisphosphonates, and those who cannot remain upright for 30 minutes after dosing. It should also be used with caution in individuals with esophageal disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 31 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.